Japan Fragile-X Syndrome Therapeutics Market to Grow at a CAGR of 3.8% to Reach USD 53.7 Billion by 2035
Market Overview
The Japan Fragile-X Syndrome Therapeutics Market is gaining traction as awareness of rare genetic and neurodevelopmental disorders increases across the country. Fragile-X syndrome, a leading inherited cause of intellectual disability and autism spectrum disorders, requires long-term therapeutic intervention. Growing emphasis on early diagnosis, patient-centric care, and...